Biosimilars Market Analysis, Challenges, Growth and Forecast By 2030

adicionou um novo artigo Outro

2023-09-19 18:00:28 -

Biosimilars are the officially approved versions of original biologic drugs, and can be manufactured when the original product’s patent expires. Biosimilars are relatively cheaper than their biologic counterparts and hence, users have come to prefer biosimilars over biologics in recent years. Biosimilars have great potential to lower costs improving patient access to life-saving medicines...

0 Comentários 0 Compartilhamentos 799 Visualizações 0 Anterior